T 1099/21 vom 15.03.2023
- Europäischer Rechtsprechungsidentifikator
- ECLI:EP:BA:2023:T109921.20230315
- Datum der Entscheidung
- 15. März 2023
- Aktenzeichen
- T 1099/21
- Antrag auf Überprüfung von
- -
- Anmeldenummer
- 07250962.3
- IPC-Klasse
- C09D 5/16A01N 43/80A01N 25/28A01P 15/00
- Verfahrenssprache
- Englisch
- Verteilung
- Nicht verteilt (D)
- Download
- Entscheidung auf Englisch
- Amtsblattfassungen
- Keine AB-Links gefunden
- Weitere Entscheidungen für diese Akte
- -
- Zusammenfassungen für diese Entscheidung
- Zusammenfassung von EPC2000 Art 123(2)
- Bezeichnung der Anmeldung
- BLENDS OF ENCAPSULATED BIOCIDES
- Name des Antragstellers
- Rohm and Haas Company
- Name des Einsprechenden
- Thor GmbH
- Kammer
- 3.3.02
- Leitsatz
- -
- Relevante Rechtsnormen
- European Patent Convention Art 100(c)European Patent Convention Art 123(2)
- Schlagwörter
- Grounds for opposition - added subject-matter
- Orientierungssatz
- Any unclarity that may arise from an ambiguity in an application as filed is to the detriment of a patent proprietor, who is ultimately responsible for the drafting of the application as filed and its claims. The fact that a feature in the application as filed is unclear cannot therefore justify or excuse the complete deletion of the unclear feature or its replacement by another feature if this results in an extension beyond the content of the application as filed. What prompted a patent proprietor to make a particular amendment to the claims cannot have any influence on the outcome of the assessment of the ground for opposition under Article 100(c) EPC (point 8 of the Reasons).
- Zitierte Akten
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The patent is revoked.